Julien De Lima
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Julien De Lima has a total of 36 co-authors. Here are the top co-authors by number of shared publications:
- Adrien Le Pluart
Nantes Université, ONIRIS, CHU Nantes, INSERM, Regenerative Medicine and Skeleton, RMeS, Nantes, France
2 shared publications - Frédéric Blanchard
Nantes Université, Oniris, CHU Nantes, INSERM, Regenerative Medicine and Skeleton, RMeS, UMR 1229, F-44000 Nantes, France
2 shared publications - Gabriel Courties
Institute of Regenerative Medicine and Biotherapy, University of Montpellier, INSERM Montpellier France
2 shared publications Laure-Agnès Chépeaux
Plateforme de Cytometrie et d'Imagerie de Masse de Montpellier, Institut de Recherche en Cancerologie de Montpellier, INSERM, University of Montpellier, Institut regional du Cancer de Montpellier, Montpellier, France
2 shared publications- Liliane Fossati-Jimack
Centre for Experimental Medicine and Rheumatology, William Harvey Research Institute, Queen Mary University of London, and Barts NIHR Biomedical Research Centre & Barts Health NHS Trust, London, UK
2 shared publications - Olivier Bortolotti
Institute of Regenerative Medicine and Biotherapy, University of Montpellier, INSERM Montpellier France
2 shared publications
Latest Publications
- Top Cited PapersOpen Access
- 22 August 2025
- Published by Elsevier in Annals of the Rheumatic Diseases
- Vol. 84 (12) , 1955-1967
Spatial mapping of rheumatoid arthritis synovial niches reveals a LYVE1+ macrophage network associated with response to therapy
- 22 August 2025
- Published by Elsevier in Annals of the Rheumatic Diseases
- Vol. 84 (12) , 1955-1967
Top Cited PapersOpen AccessSpatial mapping of rheumatoid arthritis synovial niches reveals a LYVE1+ macrophage network associated with response to therapy
- Open Access
- 23 January 2024
- Published by Elsevier in Acta Biomaterialia
- Vol. 176, 417-431
Phase composition of calcium phosphate materials affects bone formation by modulating osteoclastogenesis
- 23 January 2024
- Published by Elsevier in Acta Biomaterialia
- Vol. 176, 417-431
Open AccessPhase composition of calcium phosphate materials affects bone formation by modulating osteoclastogenesis
- Open Access
Spatial mapping of rheumatoid arthritis synovial niches reveals specific macrophage networks associated with response to therapy
Rheumatoid arthritis (RA) is a chronic inflammatory autoimmune disease affecting peripheral joints and for which approximately 40% of the patients respond insufficiently to the available synthetic or biologic disease modifying anti-rheumatic drugs (DMARDs). The infiltration of the synovial membrane by lymphocytes and monocytes profoundly alters its homeostatic functions, leading to chronic joint inflammation and bone destruction. A better understanding of how DMARDs impact the complex synovial cell social network in relationship to response/ non-response remains an unmet need to design more targeted and active therapeutic strategies. Here, we used imaging mass cytometry (IMC) to comparatively profile more than 115,000 cells in the synovial tissue of healthy, low inflammatory osteoarthritis and matched active early treatment-naïve RA patients at baseline and at 6 months after starting DMARDs treatment. We notably highlighted that tissue resident macrophages (LYVE1 + CD206 + ) in perivascular synovial niches encompassing specific subsets of vascular cells, fibroblasts and immune cells vanished in active RA but were recovered in response to DMARDs treatment. Combined ligand-receptor analysis of single-cell RNA sequencing datasets identified that IL10, C-type lectin or TAM (TYRO3, AXL and MERTK) receptors were particularly involved in the restoration of these spatial cell interactions in the context of clinical remission. In addition to providing an unprecedented synovial spatial mapping, our work uncovered novel potential cellular and molecular targets for the development of therapies for RA. One Sentence Summary: Single-cell spatial profiling of rheumatoid arthritis synovium identifies specific cell states linked to treatment response
Open AccessSpatial mapping of rheumatoid arthritis synovial niches reveals specific macrophage networks associated with response to therapy
Rheumatoid arthritis (RA) is a chronic inflammatory autoimmune disease affecting peripheral joints and for which approximately 40% of the patients respond insufficiently to the available synthetic or biologic disease modifying anti-rheumatic drugs (DMARDs). The infiltration of the synovial membrane by lymphocytes and monocytes profoundly alters its homeostatic functions, leading to chronic joint inflammation and bone destruction. A better understanding of how DMARDs impact the complex synovial cell social network in relationship to response/ non-response remains an unmet need to design more targeted and active therapeutic strategies. Here, we used imaging mass cytometry (IMC) to comparatively profile more than 115,000 cells in the synovial tissue of healthy, low inflammatory osteoarthritis and matched active early treatment-naïve RA patients at baseline and at 6 months after starting DMARDs treatment. We notably highlighted that tissue resident macrophages (LYVE1 + CD206 + ) in perivascular synovial niches encompassing specific subsets of vascular cells, fibroblasts and immune cells vanished in active RA but were recovered in response to DMARDs treatment. Combined ligand-receptor analysis of single-cell RNA sequencing datasets identified that IL10, C-type lectin or TAM (TYRO3, AXL and MERTK) receptors were particularly involved in the restoration of these spatial cell interactions in the context of clinical remission. In addition to providing an unprecedented synovial spatial mapping, our work uncovered novel potential cellular and molecular targets for the development of therapies for RA. One Sentence Summary: Single-cell spatial profiling of rheumatoid arthritis synovium identifies specific cell states linked to treatment response